U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146139) titled 'MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women' on Aug. 12.
Brief Summary: The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.
Study Start Date: March 18, 2023
Study Type: INTERVENTIONAL
Condition:
HIV Pre-exposure Prophylaxis
HIV Prevention and Care
Mobile Health Technology (mHealth)
Adherence
Doxycycline STI PEP
Intervention:
DEVICE: MyPrEP Plus Package
Participants receiving the MyPrEP P...